title: Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies.
abstract: Nuclear autoantigens in systemic lupus erythematosus are thought to derive primarily from apoptotic cells, yet there is no direct evidence that interfering with apoptosis impairs the generation of lupus autoantibodies. Here we use a mouse model that lacks the endonuclease caspase-activated DNase (CAD), resulting in an absence of chromatin and nuclear fragmentation during apoptotic cell death. We show that in this mouse, production and release into circulation of chromatin is impaired after exposure to several apoptotic triggers, but that the absence of CAD does not interfere with upstream steps of apoptosis or immune system function. Finally we show that in CAD-mutant mice, impaired lupus autoimmunity is skewed toward known cytoplasmic components, and autoimmunity toward membrane autoantigens is preserved, while autoimmunity toward chromatin and other lupus nuclear targets is severely impaired or absent. We also show, as control, that the induction of experimental autoimmune encephalomyelitis is not affected by the absence of CAD. Thus, our work in vivo strongly suggests that apoptotic molecular steps during cell death generate nuclear autoantigens to sustain the specific autoimmune response in systemic lupus erythematosus.
authors.affiliation: Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19140, USA.
authors.forename: Lorenza
authors.initials: L
authors.lastname: Frisoni
authors.forename: Lenese
authors.initials: L
authors.lastname: McPhie
authors.forename: Sun-Ah
authors.initials: SA
authors.lastname: Kang
authors.forename: Marc
authors.initials: M
authors.lastname: Monestier
authors.forename: Michael
authors.initials: M
authors.lastname: Madaio
authors.forename: Minoru
authors.initials: M
authors.lastname: Satoh
authors.forename: Roberto
authors.initials: R
authors.lastname: Caricchio
mesh_terms: D000818:Animals; D000974:Antibodies, Antinuclear / Q000096:biosynthesis* / Q000276:immunology; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D001327:Autoimmune Diseases / Q000276:immunology; D002478:Cells, Cultured; D002843:Chromatin / Q000276:immunology* / Q000378:metabolism; D053938:DNA Fragmentation; D003851:Deoxyribonucleases / Q000235:genetics; D004195:Disease Models, Animal; D005720:Gamma Rays; D007074:Immunoglobulin G / Q000276:immunology; D008070:Lipopolysaccharides / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010743:Phospholipids / Q000276:immunology; D013729:Terpenes / Q000008:administration & dosage
chemical_list: D000974:Antibodies, Antinuclear; D002843:Chromatin; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D010743:Phospholipids; D013729:Terpenes; C009042:pristane; D003851:Deoxyribonucleases; C109663:caspase-activated deoxyribonuclease